1731 |
10 Year's Journey of AMC TAVR |
Seung-Jung Park |
Aug. 04. 23 |
1730 |
A Case of Evolut Valve Migration for TAV in SAV |
Kentaro Hayashida |
Aug. 04. 23 |
1729 |
Repeated Recurrent Restenosis in a Patient with Delayed Coronary Obstruction after TAVR |
Wei-Hsian Yin |
Aug. 04. 23 |
1728 |
Case of Transcatheter Heart Valve Embolrization in the Patient with Kyphosis |
Ju Han Kim |
Aug. 04. 23 |
1727 |
Unexpected Transcatheter Valve Frame Collapse, All Hands On Deck |
Nicolas Van Mieghem |
Aug. 04. 23 |
1726 |
HALT-Pathologic Underpinnings |
Aloke V. Finn |
May. 08. 23 |
1725 |
Should Jardiance be Used as 1st Essential Medication for Heart Failure, Regardless of LVEF? |
Kyung Hoon Cho |
Apr. 20. 23 |
1724 |
Jardiance, The First Successful Result for Heart Failure with Preserved Ejection Fraction |
Wonjae Lee |
Apr. 20. 23 |
1723 |
My First Impression on using Sentinel Device during TAVI |
Si-Hyuck Kang |
Apr. 20. 23 |
1722 |
Why Should We Consider ACURATE neo2 ? - Based on Clinical Evidence |
Jeehoon Kang |
Apr. 20. 23 |